120 related articles for article (PubMed ID: 29763415)
1. Efficacy, Safety, and Cost of Therapy of the Traditional Chinese Medicine, Catalpol, in Patients Following Surgical Resection for Locally Advanced Colon Cancer.
Fei B; Dai W; Zhao S
Med Sci Monit; 2018 May; 24():3184-3192. PubMed ID: 29763415
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
[TBL] [Abstract][Full Text] [Related]
3. Amelioration by catalpol of atherosclerotic lesions in hypercholesterolemic rabbits.
Liu JY; Zhang DJ
Planta Med; 2015 Feb; 81(3):175-84. PubMed ID: 25671384
[TBL] [Abstract][Full Text] [Related]
4. Catalpol alleviates ovalbumin-induced asthma in mice: Reduced eosinophil infiltration in the lung.
Chen Y; Zhang Y; Xu M; Luan J; Piao S; Chi S; Wang H
Int Immunopharmacol; 2017 Feb; 43():140-146. PubMed ID: 27992791
[TBL] [Abstract][Full Text] [Related]
5. Catalpol suppressed proliferation, growth and invasion of CT26 colon cancer by inhibiting inflammation and tumor angiogenesis.
Zhu P; Wu Y; Yang A; Fu X; Mao M; Liu Z
Biomed Pharmacother; 2017 Nov; 95():68-76. PubMed ID: 28826099
[TBL] [Abstract][Full Text] [Related]
6. Catalpol suppresses advanced glycation end-products-induced inflammatory responses through inhibition of reactive oxygen species in human monocytic THP-1 cells.
Choi HJ; Jang HJ; Chung TW; Jeong SI; Cha J; Choi JY; Han CW; Jang YS; Joo M; Jeong HS; Ha KT
Fitoterapia; 2013 Apr; 86():19-28. PubMed ID: 23376161
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis, identification of artificial antigen of catalpol and preliminary study of immunogenicity].
Li Z; Zhang WK; Zhang Y; Di GN; Qu HH; Zhao Y; Wang QG; Xu JK
Zhongguo Zhong Yao Za Zhi; 2015 Apr; 40(7):1287-90. PubMed ID: 26281548
[TBL] [Abstract][Full Text] [Related]
8. Effect of catalpol on diabetic nephropathy in rats.
Dong Z; Chen CX
Phytomedicine; 2013 Aug; 20(11):1023-9. PubMed ID: 23746755
[TBL] [Abstract][Full Text] [Related]
9. Catalpol in Diabetes and its Complications: A Review of Pharmacology, Pharmacokinetics, and Safety.
Bai Y; Zhu R; Tian Y; Li R; Chen B; Zhang H; Xia B; Zhao D; Mo F; Zhang D; Gao S
Molecules; 2019 Sep; 24(18):. PubMed ID: 31514313
[TBL] [Abstract][Full Text] [Related]
10. Clinical observation on treatment of colonic cancer with combined treatment of chemotherapy and Chinese herbal medicine.
Zhou LY; Shan ZZ; You JL
Chin J Integr Med; 2009 Apr; 15(2):107-11. PubMed ID: 19407947
[TBL] [Abstract][Full Text] [Related]
11. Neo-adjuvant chemoradiotherapy and multivisceral resection to optimize R0 resection of locally recurrent adherent colon cancer.
Hallet J; Zih FS; Lemke M; Milot L; Smith AJ; Wong CS
Eur J Surg Oncol; 2014 Jun; 40(6):706-12. PubMed ID: 24534363
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation and metabolic profile of catalpol with human intestinal microflora by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Tao JH; Zhao M; Wang DG; Yang C; Du LY; Qiu WQ; Jiang S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1009-1010():163-9. PubMed ID: 26741989
[TBL] [Abstract][Full Text] [Related]
13. Emergency presenting colon cancer is an independent predictor of adverse disease-free survival.
Hogan J; Samaha G; Burke J; Chang KH; Condon E; Waldron D; Coffey JC
Int Surg; 2015 Jan; 100(1):77-86. PubMed ID: 25594643
[TBL] [Abstract][Full Text] [Related]
14. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases.
Bowne WB; Lee B; Wong WD; Ben-Porat L; Shia J; Cohen AM; Enker WE; Guillem JG; Paty PB; Weiser MR
Dis Colon Rectum; 2005 May; 48(5):897-909. PubMed ID: 15785892
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].
Qin Q; Yang L; Zhou AP; Sun YK; Song Y; DU F; Wang JW
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):212-6. PubMed ID: 23880003
[TBL] [Abstract][Full Text] [Related]
16. Catalpol provides protective effects against cerebral ischaemia/reperfusion injury in gerbils.
Liu YR; Li PW; Suo JJ; Sun Y; Zhang BA; Lu H; Zhu HC; Zhang GB
J Pharm Pharmacol; 2014 Sep; 66(9):1265-70. PubMed ID: 24720795
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of laparoscopic surgery in pathologic T4 colon cancers compared to those of open surgery.
Kang J; Baik SH; Lee KY; Sohn SK
Int J Colorectal Dis; 2017 Apr; 32(4):531-538. PubMed ID: 27882405
[TBL] [Abstract][Full Text] [Related]
18. Catalpol suppresses osteosarcoma cell proliferation through blocking epithelial-mesenchymal transition (EMT) and inducing apoptosis.
Wang L; Xue GB
Biochem Biophys Res Commun; 2018 Jan; 495(1):27-34. PubMed ID: 29032182
[TBL] [Abstract][Full Text] [Related]
19. LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy.
Lou YT; Chen CW; Fan YC; Chang WC; Lu CY; Wu IC; Hsu WH; Huang CW; Wang JY
PLoS One; 2014; 10(4):e0123973. PubMed ID: 25919688
[TBL] [Abstract][Full Text] [Related]
20. Young age influences treatment but not outcome of colon cancer.
Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
